Replix锐璞美股2020-02-14 23:48
$Fennec制药(FENC)$ FENC的用于预防化疗引起的儿童肿瘤患者的听觉损伤的候选药物已经提交了NDA和MAA(美国新药上市和欧洲新药上市申请),对这家公司来说是很重大的催化剂,因此能对股价造成极大的影响。预期明确,时间也很清楚,是否存在交易的机会呢?请查看:网页链接查看全文
淘沙见金2017-10-09 11:43
Fennec Pharmaceuticals ($Fennec Pharmaceuticals Inc.(FENC)$ )前身是名为Adherex Technologies Inc.的生物医药公司。曾经专注癌症疗法,不过过往的研发产品都失败了。现在的主要研发产品是硫代硫酸钠 (Sodium Thiosulfate,STS),针对的是预防顺铂用药后引起的儿童肿瘤患者的听觉损伤,目前该...查看全文
$Fennec制药(FENC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-019332 Size: 8 KB 网页链接
$Fennec制药(FENC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-019002 Size: 6 KB 网页链接
$Fennec制药(FENC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-018984 Size: 5 KB 网页链接
$Fennec制药(FENC)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-005199 Act: 33 Size: 10 KB 网页链接
$Fennec制药(FENC)$ 8-K Current report, items 5.02, 8.01, and 9.01 Accession Number: 0001104659-24-076936 Act: 34 Size: 271 KB 网页链接
$Fennec制药(FENC)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001493152-24-025449 Act: 34 Size: 162 KB 网页链接
$Fennec制药(FENC)$ 8-K Current report, item 5.07 Accession Number: 0001104659-24-074748 Act: 34 Size: 206 KB 网页链接
$Fennec制药(FENC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015201 Size: 5 KB 网页链接
$Fennec制药(FENC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015177 Size: 6 KB 网页链接
$Fennec制药(FENC)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-004301 Act: 33 Size: 9 KB 网页链接